Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.

Vascular smooth muscle cell senescence and age-related diseases: State of the art

Open access
Chi, Chen, Li, Dong-Jie, Jiang, Yu-Jie, Tong, Jie, Fu, Hui, Wu, Yi-Hang, Shen, Fu-Ming · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Abstract

Aging is a worldwide challenge, and it is accompanied by the accumulation of senescent cells. Cellular senescence is traditionally defined as permanent cell growth arrest and currently includes the senescence-associated secretory phenotype (SASP). There are two main types of cellular senescence, including telomere-dependent replicative senescence and stress-induced premature senescence. The process of cellular senescence is mainly controlled by two effector pathways, namely, the p53-p21 and p16-retinoblastoma protein (pRB) pathways. Vascular smooth muscle cells (VSMCs) are integral parts of arteries and play an important role in vascular structure and function. VSMC senescence may be triggered by many factors, such as angiotensin II, oxidative stress, inflammation, DNA damage, and small molecule compounds. These inducers are able to genetically and epigenetically regulate VSMC senescence. The senescence of VSMCs together with the SASP contributes to chronic vascular inflammation, the loss of arterial function, and the development of age-related diseases. Current evidence suggests that the senescence of VSMCs might be harmful to individual health, whereas its influence on the lifespan is not clear. The purpose of this paper was to review the current knowledge regarding VSMC senescence and its relevance to hypertension, atherosclerosis, and diabetes, as well as the potential mechanisms responsible for VSMC senescence in these age-related diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbadis.2018.08.015

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Research works printed but not linked: 157

  1. 2016, Eur. Heart J., 37, 3182, 10.1093/eurheartj/ehw468 · DOI
  2. Wang, 2009, DNA damage response and cellular senescence in tissues of aging mice, Aging Cell, 8, 311, 10.1111/j.1474-9726.2009.00481.x · DOI · Paper page
  3. Olivieri, 2013, Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment, Curr. Pharm. Des., 19, 1710
  4. Hernandez-Segura, 2018, Hallmarks of cellular senescence, Trends Cell Biol., 28, 436, 10.1016/j.tcb.2018.02.001 · DOI · Paper page
  5. Lacolley, 2012, The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles, Cardiovasc. Res., 95, 194, 10.1093/cvr/cvs135 · DOI · Paper page
  6. Lacolley, 2017, Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease, Physiol. Rev., 97, 1555, 10.1152/physrev.00003.2017 · DOI · Paper page
  7. Ruiz-Torres, 2003, Age-dependent decline of in vitro migration (basal and stimulated by IGF-1 or insulin) of human vascular smooth muscle cells, J. Gerontol. A Biol. Sci. Med. Sci., 58, B1074, 10.1093/gerona/58.12.B1074 · DOI
  8. Yin, 2016, Cellular senescence and vascular disease: novel routes to better understanding and therapy, Can. J. Cardiol., 32, 612
  9. Rubio-Ruiz, 2014, Aging in blood vessels. Medicinal agents FOR systemic arterial hypertension in the elderly, Ageing Res. Rev., 18, 132, 10.1016/j.arr.2014.10.001 · DOI
  10. Csiszar, 2012, Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment, J. Gerontol. A Biol. Sci. Med. Sci., 67, 811, 10.1093/gerona/glr228 · DOI · Paper page
  11. Gardner, 2015, Senescent vascular smooth muscle cells drive inflammation through an interleukin-1alpha-dependent senescence-associated secretory phenotype, Arterioscler. Thromb. Vasc. Biol., 35, 1963, 10.1161/ATVBAHA.115.305896 · DOI · Paper page
  12. Driscoll, 2014, Plk1 inhibition causes post-mitotic DNA damage and senescence in a range of human tumor cell lines, PLoS One, 9, 10.1371/journal.pone.0111060 · DOI
  13. Aranda-Anzaldo, 2012, The post-mitotic state in neurons correlates with a stable nuclear higher-order structure, Commun. Integr. Biol., 5, 134, 10.4161/cib.18761 · DOI
  14. Purvis, 2012, p53 dynamics control cell fate, Science (New York, N.Y.), 336, 1440, 10.1126/science.1218351 · DOI · Paper page
  15. Tsai, 2016, Reactive oxygen species derived from NADPH oxidase 1 and mitochondria mediate angiotensin II-induced smooth muscle cell senescence, J. Mol. Cell. Cardiol., 98, 18, 10.1016/j.yjmcc.2016.07.001 · DOI
  16. Cao, 2015, Ferulic acid inhibits H2O2-induced oxidative stress and inflammation in rat vascular smooth muscle cells via inhibition of the NADPH oxidase and NF-kappaB pathway, Int. Immunopharmacol., 28, 1018, 10.1016/j.intimp.2015.07.037 · DOI
  17. Kinoshita, 2017, Progerin impairs vascular smooth muscle cell growth via the DNA damage response pathway, Oncotarget, 8, 34045, 10.18632/oncotarget.15973 · DOI
  18. Sharpless, 2015, Forging a signature of in vivo senescence, Nat. Rev. Cancer, 15, 397, 10.1038/nrc3960 · DOI · Paper page
  19. Vafaie, 2014, Collagenase-resistant collagen promotes mouse aging and vascular cell senescence, Aging Cell, 13, 121, 10.1111/acel.12155 · DOI · Paper page
  20. Romero, 2015, Novel RAAS agonists and antagonists: clinical applications and controversies, Nat. Rev. Endocrinol., 11, 242, 10.1038/nrendo.2015.6 · DOI
  21. Xu, 2017, Recent progress in vascular aging: mechanisms and its role in age-related diseases, Aging and Disease, 8, 486, 10.14336/AD.2017.0507 · DOI
  22. Min, 2009, Signaling mechanisms of angiotensin II in regulating vascular senescence, Ageing Res. Rev., 8, 113, 10.1016/j.arr.2008.12.002 · DOI
  23. Wu, 2016, Resent progresses on RAAS and epigenetic regulation of essential hypertension, Chin. J. Clin. Res., 29, 988
  24. Bacanamwo, 2007, Inhibition of DNA methyltransferase inhibits the Ang II-induced increase in blood pressure, vascular remodeling and target organ damage, Circulation, 16, 124
  25. Wang, 2007, Proinflammatory profile within the grossly normal aged human aortic wall, Hypertension, 50, 219, 10.1161/HYPERTENSIONAHA.107.089409 · DOI · Paper page
  26. Jiang, 2008, Increased aortic calpain-1 activity mediates age-associated angiotensin II signaling of vascular smooth muscle cells, PLoS One, 3, 10.1371/journal.pone.0002231 · DOI
  27. Min, 2008, Angiotensin II type 2 receptor deletion enhances vascular senescence by methyl methanesulfonate sensitive 2 inhibition, Hypertension, 51, 1339, 10.1161/HYPERTENSIONAHA.107.105692 · DOI
  28. Monk, 2015, The effect of ageing on vascular smooth muscle cell behaviour—a mini-review, Gerontology, 61, 416, 10.1159/000368576 · DOI
  29. Wang, 2010, Central arterial aging and angiotensin II signaling, Curr. Hypertens. Rev., 6, 266, 10.2174/157340210793611668 · DOI
  30. Kim, 2018, The protective effect of resveratrol on vascular aging by modulation of the renin-angiotensin system, Atherosclerosis, 270, 123, 10.1016/j.atherosclerosis.2018.01.043 · DOI
  31. Xu, 2017, Celastrol alleviates angiotensin IImediated vascular smooth muscle cell senescence via induction of autophagy, Mol. Med. Rep., 16, 7657, 10.3892/mmr.2017.7533 · DOI
  32. Zhou, 2016, Activation of Nrf2 contributes to the protective effect of Exendin-4 against angiotensin II-induced vascular smooth muscle cell senescence, Am. J. Physiol. Cell Physiol., 311, C572, 10.1152/ajpcell.00093.2016 · DOI · Paper page
  33. Li, 2016, alpha7 nicotinic acetylcholine receptor relieves angiotensin II-induced senescence in vascular smooth muscle cells by raising nicotinamide adenine dinucleotide-dependent SIRT1 activity, Arterioscler. Thromb. Vasc. Biol., 36, 1566, 10.1161/ATVBAHA.116.307157 · DOI
  34. Fields, 2014, Biophysical studies of matrix metalloproteinase/triple-helix complexes, Adv. Protein Chem. Struct. Biol., 97, 37, 10.1016/bs.apcsb.2014.09.001 · DOI
  35. Wang, 2018, Matrix metalloproteinases, vascular remodeling, and vascular disease, Adv. Pharmacol. (San Diego, Calif), 81, 241
  36. Jiang, 2012, Calpain-1 regulation of matrix metalloproteinase 2 activity in vascular smooth muscle cells facilitates age-associated aortic wall calcification and fibrosis, Hypertension, 60, 1192, 10.1161/HYPERTENSIONAHA.112.196840 · DOI
  37. Ma, 2015, Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence, Cardiovasc. Res., 106, 421, 10.1093/cvr/cvv128 · DOI
  38. Spinetti, 2004, Rat aortic MCP-1 and its receptor CCR2 increase with age and alter vascular smooth muscle cell function, Arterioscler. Thromb. Vasc. Biol., 24, 1397, 10.1161/01.ATV.0000134529.65173.08 · DOI · Paper page
  39. Harvey, 2016, Vascular fibrosis in aging and hypertension: molecular mechanisms and clinical implications, Can. J. Cardiol., 32, 659
  40. Pohlers, 2009, TGF-beta and fibrosis in different organs — molecular pathway imprints, Biochim. Biophys. Acta, 1792, 746, 10.1016/j.bbadis.2009.06.004 · DOI · Paper page
  41. Weigert, 2002, Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia, Diabetologia, 45, 890, 10.1007/s00125-002-0843-4 · DOI
  42. Zeng, 1996, Endogenous TGF-beta activity is modified during cellular aging: effects on metalloproteinase and TIMP-1 expression, Exp. Cell Res., 228, 271, 10.1006/excr.1996.0326 · DOI
  43. Fleenor, 2010, Arterial stiffening with ageing is associated with transforming growth factor-beta1-related changes in adventitial collagen: reversal by aerobic exercise, J. Physiol., 588, 3971, 10.1113/jphysiol.2010.194753 · DOI · Paper page
  44. Buford, 2016, Hypertension and aging, Ageing Res. Rev., 26, 96, 10.1016/j.arr.2016.01.007 · DOI · Paper page
  45. Zelko, 2011, Histone acetylation regulates the cell-specific and interferon-gamma-inducible expression of extracellular superoxide dismutase in human pulmonary arteries, Am. J. Respir. Cell Mol. Biol., 45, 953, 10.1165/rcmb.2011-0012OC · DOI
  46. Xu, 2013, Profile of P66SHC expression and histone modifications in replicative cell senescence and oxidative-stress induced premature senescence, Wei Sheng Yan Jiu, 42, 777
  47. Zhang, 2010, Epigenetic enhancement of p66Shc during cellular replicative or premature senescence, Toxicology, 278, 189, 10.1016/j.tox.2010.07.011 · DOI
  48. Moon, 2001, Aging, oxidative responses, and proliferative capacity in cultured mouse aortic smooth muscle cells, Am. J. Phys. Heart Circ. Phys., 280, H2779
  49. Feng, 2017, The matrikine N-acetylated proline-glycine-proline induces premature senescence of nucleus pulposus cells via CXCR1-dependent ROS accumulation and DNA damage and reinforces the destructive effect of these cells on homeostasis of intervertebral discs, Biochim. Biophys. Acta, 1863, 220, 10.1016/j.bbadis.2016.10.011 · DOI
  50. El Assar, 2013, Oxidative stress and vascular inflammation in aging, Free Radic. Biol. Med., 65, 380, 10.1016/j.freeradbiomed.2013.07.003 · DOI · Paper page
  51. Ungvari, 2008, Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats, Am. J. Phys. Heart Circ. Phys., 294, H2121
  52. Lozhkin, 2017, NADPH oxidase 4 regulates vascular inflammation in aging and atherosclerosis, J. Mol. Cell. Cardiol., 102, 10, 10.1016/j.yjmcc.2016.12.004 · DOI
  53. Vendrov, 2015, NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease, Antioxid. Redox Signal., 23, 1389, 10.1089/ars.2014.6221 · DOI · Paper page
  54. Vasa-Nicotera, 2011, miR-146a is modulated in human endothelial cell with aging, Atherosclerosis, 217, 326, 10.1016/j.atherosclerosis.2011.03.034 · DOI · Paper page
  55. Siuda, 2012, Transcriptional regulation of Nox4 by histone deacetylases in human endothelial cells, Basic Res. Cardiol., 107, 283, 10.1007/s00395-012-0283-3 · DOI
  56. Przybylska, 2016, NOX4 downregulation leads to senescence of human vascular smooth muscle cells, Oncotarget, 7, 66429, 10.18632/oncotarget.12079 · DOI
  57. Vassileva, 2014, Inflammation: the dynamic force of health and disease, Clin. Pharmacol. Ther., 96, 401, 10.1038/clpt.2014.150 · DOI
  58. Scrivo, 2011, Inflammation as “common soil” of the multifactorial diseases, Autoimmun. Rev., 10, 369, 10.1016/j.autrev.2010.12.006 · DOI · Paper page
  59. Sarkar, 2006, Molecular mechanisms of aging-associated inflammation, Cancer Lett., 236, 13, 10.1016/j.canlet.2005.04.009 · DOI · Paper page
  60. Martinon, 2010, Signaling by ROS drives inflammasome activation, Eur. J. Immunol., 40, 616, 10.1002/eji.200940168 · DOI · Paper page
  61. Ni, 2016, Vagus nerve attenuates hepatocyte apoptosis upon ischemia-reperfusion via alpha7 nicotinic acetylcholine receptor on Kupffer cells in mice, Anesthesiology, 125, 1005, 10.1097/ALN.0000000000001309 · doi:10.1097/aln.0000000000001309
  62. Li, 2014, Activation of alpha7 nicotinic acetylcholine receptor protects against oxidant stress damage through reducing vascular peroxidase-1 in a JNK signaling-dependent manner in endothelial cells, Cell. Physiol. Biochem., 33, 468, 10.1159/000358627 · DOI
  63. Leavy, 2014, Inflammation: regulating ROS, Nat. Rev. Immunol., 14, 357, 10.1038/nri3685 · DOI
  64. Cencioni, 2013, Oxidative stress and epigenetic regulation in ageing and age-related diseases, Int. J. Mol. Sci., 14, 17643, 10.3390/ijms140917643 · DOI · Paper page
  65. Chen, 2018, Activation of DNA demethylases attenuates aging-associated arterial stiffening and hypertension, Aging Cell, 17, 10.1111/acel.12762 · DOI
  66. Schiattarella, 2018, Epigenetic modulation of vascular diseases: assessing the evidence and exploring the opportunities, Vasc. Pharmacol., 107, 43, 10.1016/j.vph.2018.02.009 · DOI
  67. Pietra, 2015, Restoring histone deacetylase activity by waste product release. A view from molecular mechanics simulations with mammalian HDAC8, Chem. Biodivers., 12, 503, 10.1002/cbdv.201400314 · DOI
  68. Badi, 2015, MicroRNA-34a induces vascular smooth muscle cells senescence by SIRT1 downregulation and promotes the expression of age-associated pro-inflammatory secretory factors, J. Gerontol. A Biol. Sci. Med. Sci., 70, 1304, 10.1093/gerona/glu180 · DOI
  69. Nicholson, 2017, MicroRNA-203 mimics age-related aortic smooth muscle dysfunction of cytoskeletal pathways, J. Cell. Mol. Med., 21, 81, 10.1111/jcmm.12940 · DOI
  70. Zheng, 2015, miR-200c-SUMOylated KLF4 feedback loop acts as a switch in transcriptional programs that control VSMC proliferation, J. Mol. Cell. Cardiol., 82, 201, 10.1016/j.yjmcc.2015.03.011 · DOI
  71. Lin, 2016, MiR-135a suppresses calcification in senescent VSMCs by regulating KLF4/STAT3 pathway, Curr. Vasc. Pharmacol., 14, 211, 10.2174/1570161113666150722151817 · DOI
  72. De Meyer, 2015, Autophagy in vascular disease, Circ. Res., 116, 468, 10.1161/CIRCRESAHA.116.303804 · DOI · Paper page
  73. Luo, 2017, Moderate autophagy inhibits vascular smooth muscle cell senescence to stabilize progressed atherosclerotic plaque via the mTORC1/ULK1/ATG13 signal pathway, Oxidative Med. Cell. Longev., 2017, 3018190, 10.1155/2017/3018190 · DOI
  74. Sung, 2017, Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16, Exp. Gerontol., 109, 51, 10.1016/j.exger.2017.08.001 · DOI
  75. Frudd, 2018, Oxidation of Atg3 and Atg7 mediates inhibition of autophagy, Nat. Commun., 9, 95, 10.1038/s41467-017-02352-z · DOI · Paper page
  76. Wang, 2007, Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53, J. Cardiovasc. Pharmacol., 49, 253, 10.1097/FJC.0b013e318033dfb3 · DOI
  77. Kitada, 2016, The protective role of Sirt1 in vascular tissue: its relationship to vascular aging and atherosclerosis, Aging, 8, 2290, 10.18632/aging.101068 · DOI · Paper page
  78. Kearney, 2005, Global burden of hypertension: analysis of worldwide data, Lancet (London, England), 365, 217, 10.1016/S0140-6736(05)17741-1 · DOI · Paper page
  79. Morgan, 2014, Role of arterial telomere dysfunction in hypertension: relative contributions of telomere shortening and telomere uncapping, J. Hypertens., 32, 1293, 10.1097/HJH.0000000000000157 · DOI
  80. Kim, 2009, Downregulation of angiotensin II-induced 12-lipoxygenase expression and cell proliferation in vascular smooth muscle cells from spontaneously hypertensive rats by CCL5, Korean J. Physiol. Pharmacol., 13, 385, 10.4196/kjpp.2009.13.5.385 · doi:10.4196/kjpp.2009.13.5.385
  81. Westhoff, 2008, Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a, Hypertension, 52, 123, 10.1161/HYPERTENSIONAHA.107.099432 · DOI · Paper page
  82. Seven, 2015, Adipocytokines, C-reactive protein, and cardiovascular disease: a population-based prospective study, PLoS One, 10, 10.1371/journal.pone.0128987 · DOI
  83. Sesso, 2015, Plasma inflammatory markers and the risk of developing hypertension in men, J. Am. Heart Assoc., 4, 10.1161/JAHA.115.001802 · DOI
  84. Demirbas, 2002, Plasma tumor necrosis factor-alpha levels and insulin resistance in nondiabetic hypertensive subjects, Horm. Res., 58, 283
  85. Sardo, 2004, Effects of AT1 receptor antagonist losartan on sICAM-1 and TNF-alpha levels in uncomplicated hypertensive patients, Angiology, 55, 195, 10.1177/000331970405500212 · DOI
  86. Koz, 2009, The effects of perindopril on aortic elasticity and inflammatory markers in hypertensive patients, Med. Sci. Monit., 15, PI41
  87. Derosa, 2015, Perindopril and barnidipine alone or combined with simvastatin on hepatic steatosis and inflammatory parameters in hypertensive patients, Eur. J. Pharmacol., 766, 31, 10.1016/j.ejphar.2015.09.030 · DOI
  88. Dorr, 2015, Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension, Clin. Res. Cardiol., 104, 175, 10.1007/s00392-014-0773-4 · DOI
  89. Li, 2011, Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension, Hypertension, 57, 298, 10.1161/HYPERTENSIONAHA.110.160077 · DOI
  90. Brown, 2015, Regulation of signal transduction by reactive oxygen species in the cardiovascular system, Circ. Res., 116, 531, 10.1161/CIRCRESAHA.116.303584 · DOI · Paper page
  91. Touyz, 2001, Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways, J. Hypertens., 19, 1245, 10.1097/00004872-200107000-00009 · DOI · Paper page
  92. Guzik, 2017, Oxidative stress, inflammation, and vascular aging in hypertension, Hypertension, 70, 660, 10.1161/HYPERTENSIONAHA.117.07802 · DOI · Paper page
  93. Miao, 2017, Accumulation of smooth muscle 22alpha protein accelerates senescence of vascular smooth muscle cells via stabilization of p53 in vitro and in vivo, Arterioscler. Thromb. Vasc. Biol., 37, 1849, 10.1161/ATVBAHA.117.309378 · DOI
  94. Gao, 2016, Activation of SIRT1 attenuates klotho deficiency-induced arterial stiffness and hypertension by enhancing AMP-activated protein kinase activity, Hypertension, 68, 1191, 10.1161/HYPERTENSIONAHA.116.07709 · DOI
  95. Nilsson, 2014, Hemodynamic aging as the consequence of structural changes associated with early vascular aging (EVA), Aging and Disease, 5, 109
  96. Chamley-Campbell, 1979, The smooth muscle cell in culture, Physiol. Rev., 59, 1, 10.1152/physrev.1979.59.1.1 · DOI · Paper page
  97. Lopez-Andres, 2013, Absence of cardiotrophin 1 is associated with decreased age-dependent arterial stiffness and increased longevity in mice, Hypertension, 61, 120, 10.1161/HYPERTENSIONAHA.112.201699 · DOI
  98. Barbaro, 2015, Increased arterial stiffness in resistant hypertension is associated with inflammatory biomarkers, Blood Press., 24, 7, 10.3109/08037051.2014.940710 · DOI
  99. Zhou, 2017, Rho kinase regulates aortic vascular smooth muscle cell stiffness via actin/SRF/myocardin in hypertension, Cell. Physiol. Biochem., 44, 701, 10.1159/000485284 · DOI
  100. Wirth, 2016, Age-dependent blood pressure elevation is due to increased vascular smooth muscle tone mediated by G-protein signalling, Cardiovasc. Res., 109, 131, 10.1093/cvr/cvv249 · DOI
  101. Zhu, 2018, TGFbeta1 reinforces arterial aging in the vascular smooth muscle cell through a long-range regulation of the cytoskeletal stiffness, Sci. Rep., 8, 2668, 10.1038/s41598-018-20763-w · DOI
  102. Chow, 2015, The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis, Heart Fail. Rev., 20, 291, 10.1007/s10741-015-9471-1 · DOI
  103. Nakano-Kurimoto, 2009, Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition, Am. J. Phys. Heart Circ. Phys., 297, H1673
  104. Kim, 2018, Smooth muscle cell-mineralocorticoid receptor as a mediator of cardiovascular stiffness with aging, Hypertension, 71, 609, 10.1161/HYPERTENSIONAHA.117.10437 · DOI
  105. McCurley, 2012, Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors, Nat. Med., 18, 1429, 10.1038/nm.2891 · DOI · Paper page
  106. Krug, 2010, Hypertension, 55, 1476, 10.1161/HYPERTENSIONAHA.109.148783 · DOI
  107. Qiu, 2010, Short communication: vascular smooth muscle cell stiffness as a mechanism for increased aortic stiffness with aging, Circ. Res., 107, 615, 10.1161/CIRCRESAHA.110.221846 · DOI · Paper page
  108. Sehgel, 2015, Augmented vascular smooth muscle cell stiffness and adhesion when hypertension is superimposed on aging, Hypertension, 65, 370, 10.1161/HYPERTENSIONAHA.114.04456 · DOI
  109. Galkina, 2009, Immune and inflammatory mechanisms of atherosclerosis, Annu. Rev. Immunol., 27, 165, 10.1146/annurev.immunol.021908.132620 · DOI · Paper page
  110. Glass, 2001, Atherosclerosis. The road ahead, Cell, 104, 503, 10.1016/S0092-8674(01)00238-0 · DOI · Paper page
  111. Falk, 2013, Update on acute coronary syndromes: the pathologists' view, Eur. Heart J., 34, 719, 10.1093/eurheartj/ehs411 · DOI · Paper page
  112. Jeng, 1994, Extracranial carotid atherosclerosis and vascular risk factors in different types of ischemic stroke in Taiwan, Stroke, 25, 1989, 10.1161/01.STR.25.10.1989 · DOI
  113. Bos, 2012, Intracranial carotid artery atherosclerosis: prevalence and risk factors in the general population, Stroke, 43, 1878, 10.1161/STROKEAHA.111.648667 · DOI · Paper page
  114. Lusis, 2000, Atherosclerosis, Nature, 407, 233, 10.1038/35025203 · DOI · Paper page
  115. Bennett, 1995, Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques, J. Clin. Invest., 95, 2266, 10.1172/JCI117917 · DOI · Paper page
  116. Lebron, 1998, Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor, Cell, 93, 111, 10.1016/S0092-8674(00)81151-4 · DOI · Paper page
  117. Kunieda, 2006, Angiotensin II induces premature senescence of vascular smooth muscle cells and accelerates the development of atherosclerosis via a p21-dependent pathway, Circulation, 114, 953, 10.1161/CIRCULATIONAHA.106.626606 · DOI · Paper page
  118. Bennett, 1998, Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques, Circ. Res., 82, 704, 10.1161/01.RES.82.6.704 · DOI · Paper page
  119. Salpea, 2010, Telomere length in atherosclerosis and diabetes, Atherosclerosis, 209, 35, 10.1016/j.atherosclerosis.2009.12.021 · DOI
  120. Minamino, 2010, Role of cellular senescence in lifestyle-related disease, Circ. J., 74, 2527, 10.1253/circj.CJ-10-0916 · DOI
  121. Finn, 2010, Concept of vulnerable/unstable plaque, Arterioscler. Thromb. Vasc. Biol., 30, 1282, 10.1161/ATVBAHA.108.179739 · DOI · Paper page
  122. Gray, 2015, Effects of DNA damage in smooth muscle cells in atherosclerosis, Circ. Res., 116, 816, 10.1161/CIRCRESAHA.116.304921 · DOI
  123. Fakhry, 2017, TNAP stimulates vascular smooth muscle cell trans-differentiation into chondrocytes through calcium deposition and BMP-2 activation: possible implication in atherosclerotic plaque stability, Biochim. Biophys. Acta, 1863, 643, 10.1016/j.bbadis.2016.12.003 · DOI
  124. Li, 2010, Age-related changes in redox signaling and VSMC function, Antioxid. Redox Signal., 12, 641, 10.1089/ars.2009.2854 · DOI
  125. Xu, 2014, Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques, Redox Biol., 2, 642, 10.1016/j.redox.2014.04.004 · DOI
  126. Song, 2012, Aging enhances the basal production of IL-6 and CCL2 in vascular smooth muscle cells, Arterioscler. Thromb. Vasc. Biol., 32, 103, 10.1161/ATVBAHA.111.236349 · DOI
  127. Fyhrquist, 2013, The roles of senescence and telomere shortening in cardiovascular disease, Nat. Rev. Cardiol., 10, 274, 10.1038/nrcardio.2013.30 · DOI · Paper page
  128. Martinet, 2002, Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques, Circulation, 106, 927, 10.1161/01.CIR.0000026393.47805.21 · DOI · Paper page
  129. Mahmoudi, 2008, Statins use a novel Nijmegen breakage syndrome-1-dependent pathway to accelerate DNA repair in vascular smooth muscle cells, Circ. Res., 103, 717, 10.1161/CIRCRESAHA.108.182899 · DOI
  130. Yu, 2013, Mitochondrial DNA damage can promote atherosclerosis independently of reactive oxygen species through effects on smooth muscle cells and monocytes and correlates with higher-risk plaques in humans, Circulation, 128, 702, 10.1161/CIRCULATIONAHA.113.002271 · DOI · Paper page
  131. Wang, 2016, FGF21 represses cerebrovascular aging via improving mitochondrial biogenesis and inhibiting p53 signaling pathway in an AMPK-dependent manner, Exp. Cell Res., 346, 147, 10.1016/j.yexcr.2016.06.020 · DOI
  132. Mendelsohn, 2015, Telomerase reverse transcriptase and peroxisome proliferator-activated receptor gamma co-activator-1alpha cooperate to protect cells from DNA damage and mitochondrial dysfunction in vascular senescence, Rejuvenation Res., 18, 479, 10.1089/rej.2015.1780 · DOI
  133. Zhang, 2017, Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging, Biochim. Biophys. Acta, 1863, 1919, 10.1016/j.bbadis.2017.03.016 · DOI
  134. Wang, 2016, mTOR-Independent autophagy inducer trehalose rescues against insulin resistance-induced myocardial contractile anomalies: role of p38 MAPK and Foxo1, Pharmacol. Res., 111, 357, 10.1016/j.phrs.2016.06.024 · DOI
  135. Wang, 2018, Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy, J. Mol. Cell. Cardiol., 119, 40, 10.1016/j.yjmcc.2018.04.009 · DOI
  136. Lv, 2017, Downregulation of Pin1 in human atherosclerosis and its association with vascular smooth muscle cell senescence, J. Vasc. Surg.
  137. Mercer, 2005, Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice, Circ. Res., 96, 667, 10.1161/01.RES.0000161069.15577.ca · DOI · Paper page
  138. Khanna, 2009, Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis, J. Biomed. Sci., 16, 66, 10.1186/1423-0127-16-66 · DOI
  139. Grunberger, 2018, American Association of Clinical Endocrinologists and American College of Endocrinology 2018 position statement on integration of insulin pumps and continuous glucose monitoring in patients with diabetes mellitus, Endocr. Pract., 24, 302, 10.4158/PS-2017-0155 · DOI
  140. Katsuumi, 2018, Vascular senescence in cardiovascular and metabolic diseases, Front. Cardiovasc. Med., 5, 18, 10.3389/fcvm.2018.00018 · DOI · Paper page
  141. Goldstein, 1984, Cellular and molecular biological studies on diabetes mellitus, Pathol. Biol., 32, 99
  142. Simm, 2013, Protein glycation during aging and in cardiovascular disease, J. Proteome, 92, 248, 10.1016/j.jprot.2013.05.012 · DOI
  143. Guo, 2018, Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-kappaB-mediated inflammation both in vitro and in vivo, Biochim. Biophys. Acta, 1864, 238, 10.1016/j.bbadis.2017.09.029 · DOI
  144. Fukagawa, 2001, Modulation of cell injury and survival by high glucose and advancing age, Free Radic. Biol. Med., 31, 1560, 10.1016/S0891-5849(01)00736-5 · DOI
  145. Zhang, 2017, iNOS-derived peroxynitrite mediates high glucose-induced inflammatory gene expression in vascular smooth muscle cells through promoting KLF5 expression and nitration, Biochim. Biophys. Acta, 1863, 2821, 10.1016/j.bbadis.2017.07.004 · DOI
  146. Wang, 2017, Ablation of Akt2 prevents paraquat-induced myocardial mitochondrial injury and contractile dysfunction: role of Nrf2, Toxicol. Lett., 269, 1, 10.1016/j.toxlet.2017.01.009 · DOI
  147. Ren, 2017, Akt2 ablation prolongs life span and improves myocardial contractile function with adaptive cardiac remodeling: role of Sirt1-mediated autophagy regulation, Aging Cell, 16, 976, 10.1111/acel.12616 · DOI
  148. Sampson, 2006, Chromosomal telomere attrition as a mechanism for the increased risk of epithelial cancers and senescent phenotypes in type 2 diabetes, Diabetologia, 49, 1726, 10.1007/s00125-006-0322-4 · DOI
  149. Zhang, 2015, Metformin and resveratrol inhibited high glucose-induced metabolic memory of endothelial senescence through SIRT1/p300/p53/p21 pathway, PLoS One, 10
  150. Li, 2003, Age-related differences in MAP kinase activity in VSMC in response to glucose or TNF-alpha, J. Cell. Physiol., 197, 418, 10.1002/jcp.10384 · doi:10.1002/jcp.10384
  151. Pandolfi, 2007, Chronic hyperglicemia and nitric oxide bioavailability play a pivotal role in pro-atherogenic vascular modifications, Genes Nutr., 2, 195, 10.1007/s12263-007-0050-5 · DOI
  152. Lee, 2018, Gliclazide, a KATP channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKbeta-AMPK pathway, Vasc. Pharmacol., 102, 21, 10.1016/j.vph.2018.01.001 · DOI
  153. Gizard, 2008, Transcriptional control of vascular smooth muscle cell proliferation by peroxisome proliferator-activated receptor-gamma: therapeutic implications for cardiovascular diseases, PPAR Res., 2008, 429123, 10.1155/2008/429123 · DOI
  154. Vasto, 2007, Inflammatory networks in ageing, age-related diseases and longevity, Mech. Ageing Dev., 128, 83, 10.1016/j.mad.2006.11.015 · DOI · Paper page
  155. Li, 2018, Inhibition of vascular smooth muscle cells premature senescence with rutin attenuates and stabilizes diabetic atherosclerosis, J. Nutr. Biochem., 51, 91, 10.1016/j.jnutbio.2017.09.012 · DOI
  156. Ruiz-Torres, 2005, On maximum human life span: interdisciplinary approach about its limits, Advances in Gerontology = Uspekhi gerontologii, 16, 14
  157. Martin, 1983, Comparative rates of decline in the primary cloning efficiencies of smooth muscle cells from the aging thoracic aorta of two murine species of contrasting maximum life span potentials, Am. J. Pathol., 110, 236

Cited by

See all 158

Metadata

Authors
Chi, C., Li, D.-J., Jiang, Y.-J., Tong, J., Fu, H., Wu, Y.-H., & Shen, F.-M.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Publisher
Elsevier BV
Published
2019-07
Volume
1865
Issue
7
Pages
1810-1821
ISSN
0925-4439 (ISSN-L)
OpenAlex
W2885511418
Cited by
158
References
36
FWCI
7.27
Type
journal article
Language
en
Open access
bronze
Licence
Funders
  • Shanghai Municipal Health and Family Planning Commission Foundation (2016ZB0306)
  • National Natural Science Foundation of China (81773719, 81703590)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular smooth muscle cell senescence and age-related diseases: State of the art. https://app.cochat.ai/papers/10.1016/j.bbadis.2018.08.015
The paper
Chi, C., Li, D.-J., Jiang, Y.-J., Tong, J., Fu, H., Wu, Y.-H., & Shen, F.-M. (2019). Vascular smooth muscle cell senescence and age-related diseases: State of the art. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. https://doi.org/10.1016/j.bbadis.2018.08.015

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.